A New Research Report on Diabetes in 5 EU Member States

Researchers at the Medical Technology Research Group, LSE Health (Panos Kanavos, Stacey van den Aardweg and Willemien Schurer) have published a new report on the costs, outcomes and management of diabetes in 5 EU countries. Diabetes mellitus (DM) is associated with a high risk of developing complications and severe co-morbidities. Over the past few years, diabetes (Type 1 and 2) and its associated costs have risen, particularly those related to treatment of complications.

The objective of this research is to identify and compare diabetes burden of disease, costs (direct and indirect) and diabetes outcomes, focusing on complications across France, Germany, Italy, Spain, and the UK (EU5). This will increase our understanding of the state of diabetes management in EU5 from which to make informed policy recommendations.

A survey was designed and sent to health economists in the EU5 countries. In turn, key diabetes clinicians, decision makers and health officials were interviewed in order to answer the survey. In addition, secondary data was collected from PubMed, diabetes association publications and health government publications and websites, including national statistics.

See full details on the LSE website  or Download the report

Save the date

Participants at conference

FEND
23rd Annual Conference
28-29 Sept 2018

Berlin, Germany